Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0055 AUD | +10.00% | 0.00% | +10.00% |
08/05 | Invion Partners with Hanlim Pharma for Glioblastoma Treatment | MT |
05/03 | Invion's Anti-Cancer Drug Logs Postive Preclinical Trial Results | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
2.13Cr | - | - | - | - | - | |
6.26TCr | - | |||||
4.12TCr | ||||||
4.03TCr | ||||||
2.79TCr | ||||||
2.62TCr |
- Stock Market
- Equities
- IVX Stock
- Charts Invion Limited
- Sector Chart